Further, we tested six genes (CCDC122, NUDT15, PVT1, TRMT12, RPL30, and UBR5) in different cohorts of PCa patients from mixed origin and demonstrated their 5hmC and gene expression levels are associated with poor progression-free survival. This evidence concerns the gene PVT1 and posterior cortical atrophy.